Compounds for the inhibition of undesired cell proliferation and use thereof

Details for Australian Patent Application No. 2004308619 (hide)

Owner Jerini AG

Inventors Schutkowski, Mike; Tradler, Thomas; Gibson, Christoph; Jobron, Laurence; Zischinsky, Gunther; Hummel, Gerd; Knolle, Jochen; Christner, Claudia

Agent Pizzeys

Pub. Number AU-A-2004308619

PCT Pub. Number WO2005/063259

Priority 03029450.8 19.12.03 EP

Filing date 18 December 2004

Wipo publication date 14 July 2005

International Classifications

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

C07F 9/59 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/6553 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/6558 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/063259 Priority application(s): WO2005/063259

12 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004308627-Method for separating trioxane from a mixture containing trioxane, formaldehyde and water

2004308616-Composition comprising an aqueous extract of red vine leaves and a blood circulation-improving agent for the treatment of chronic venous insufficiences